OpGen Inc. Reports 52% Revenue Increase to $5.2 Million in 2024, Driven by Listing Sponsorship Services; Product Sales Decline Significantly

Reuters
08/22
OpGen Inc. Reports 52% Revenue Increase to $5.2 Million in 2024, Driven by Listing Sponsorship Services; Product Sales Decline Significantly

OpGen Inc. has released its annual financial results for the fiscal year ending December 31, 2024. The company reported a shift in its revenue streams following the acquisition by AEI Capital Ltd. and the establishment of CapForce as a wholly-owned subsidiary. Revenue was generated from CapForce's listing sponsorship and consulting services, marking a change from previous years where product sales and laboratory services were the primary sources. The company did not disclose specific figures for net income or losses. However, it indicated that financing arrangements with AEI Capital Ltd. will be pivotal for future operations. OpGen's repositioned business model also reflects a change in cost structure. The cost of sales now primarily includes subcontractor and advisor fees and technology infrastructure costs. Research and development expenses are focused on developing the digital investment banking platform. Looking ahead, OpGen anticipates continued revenue generation from CapForce's services and plans to strategically use financing opportunities to strengthen its financial position. The company is focused on expanding and innovating within its current business framework.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OpGen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-25-006628), on August 21, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10